LYMPHOMA, DIFFUSE LARGE B-CELL
Clinical trials for LYMPHOMA, DIFFUSE LARGE B-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, DIFFUSE LARGE B-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, DIFFUSE LARGE B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for blood cancer patients: experimental drug enters human trials
Disease control Recruiting nowThis study is testing an experimental drug called LY4584180 in adults with certain blood cancers (like lymphoma) that have not improved after at least two prior treatments. The main goals are to check the drug's safety, how the body processes it, and whether it can shrink tumors.…
Matched conditions: LYMPHOMA, DIFFUSE LARGE B-CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
Off-the-Shelf CAR-T therapy offers new hope for tough blood cancers
Disease control Recruiting nowThis study tests a new CAR-T therapy called Allo-QuadCAR01-T for people with B-cell cancers that have not responded to other treatments. Unlike current therapies that use a patient's own cells, this one uses donor cells that are ready to use, saving time and reducing cost. It tar…
Matched conditions: LYMPHOMA, DIFFUSE LARGE B-CELL
Phase: PHASE1, PHASE2 • Sponsor: AvenCell Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC